tetano
Editor, Senior Moderator
Nat Commun
. 2024 Jul 23;15(1):6219.
doi: 10.1038/s41467-024-50566-9. Mutational profiling of SARS-CoV-2 papain-like protease reveals requirements for function, structure, and drug escape
Xinyu Wu[SUP] 1 2 [/SUP], Margareta Go[SUP] 1 [/SUP], Julie V Nguyen[SUP] 1 [/SUP], Nathan W Kuchel[SUP] 1 2 [/SUP], Bernadine G C Lu[SUP] 1 2 [/SUP], Kathleen Zeglinski[SUP] 1 2 [/SUP], Kym N Lowes[SUP] 1 2 [/SUP], Dale J Calleja[SUP] 1 2 [/SUP], Jeffrey P Mitchell[SUP] 1 2 [/SUP], Guillaume Lessene[SUP] 1 2 3 [/SUP], David Komander[SUP] 1 2 [/SUP], Matthew E Call[SUP] 1 2 [/SUP], Melissa J Call[SUP] 4 5 [/SUP]
Affiliations
Papain-like protease (PLpro) is an attractive drug target for SARS-CoV-2 because it is essential for viral replication, cleaving viral poly-proteins pp1a and pp1ab, and has de-ubiquitylation and de-ISGylation activities, affecting innate immune responses. We employ Deep Mutational Scanning to evaluate the mutational effects on PLpro enzymatic activity and protein stability in mammalian cells. We confirm features of the active site and identify mutations in neighboring residues that alter activity. We characterize residues responsible for substrate binding and demonstrate that although residues in the blocking loop are remarkably tolerant to mutation, blocking loop flexibility is important for function. We additionally find a connected network of mutations affecting activity that extends far from the active site. We leverage our library to identify drug-escape variants to a common PLpro inhibitor scaffold and predict that plasticity in both the S4 pocket and blocking loop sequence should be considered during the drug design process.
. 2024 Jul 23;15(1):6219.
doi: 10.1038/s41467-024-50566-9. Mutational profiling of SARS-CoV-2 papain-like protease reveals requirements for function, structure, and drug escape
Xinyu Wu[SUP] 1 2 [/SUP], Margareta Go[SUP] 1 [/SUP], Julie V Nguyen[SUP] 1 [/SUP], Nathan W Kuchel[SUP] 1 2 [/SUP], Bernadine G C Lu[SUP] 1 2 [/SUP], Kathleen Zeglinski[SUP] 1 2 [/SUP], Kym N Lowes[SUP] 1 2 [/SUP], Dale J Calleja[SUP] 1 2 [/SUP], Jeffrey P Mitchell[SUP] 1 2 [/SUP], Guillaume Lessene[SUP] 1 2 3 [/SUP], David Komander[SUP] 1 2 [/SUP], Matthew E Call[SUP] 1 2 [/SUP], Melissa J Call[SUP] 4 5 [/SUP]
Affiliations
- PMID: 39043718
- PMCID: PMC11266423
- DOI: 10.1038/s41467-024-50566-9
Papain-like protease (PLpro) is an attractive drug target for SARS-CoV-2 because it is essential for viral replication, cleaving viral poly-proteins pp1a and pp1ab, and has de-ubiquitylation and de-ISGylation activities, affecting innate immune responses. We employ Deep Mutational Scanning to evaluate the mutational effects on PLpro enzymatic activity and protein stability in mammalian cells. We confirm features of the active site and identify mutations in neighboring residues that alter activity. We characterize residues responsible for substrate binding and demonstrate that although residues in the blocking loop are remarkably tolerant to mutation, blocking loop flexibility is important for function. We additionally find a connected network of mutations affecting activity that extends far from the active site. We leverage our library to identify drug-escape variants to a common PLpro inhibitor scaffold and predict that plasticity in both the S4 pocket and blocking loop sequence should be considered during the drug design process.